The influence of different intravascular volume replacement regimens on renal function in the elderly

Anesthesia and Analgesia

Volumn 89, Issue 5, 1999, Pages 1124-1130

  Kumle, Bernhard ^a   Boldt, Joachim ^a   Piper, Sven ^a   Schmidt, Christian ^a   Suttner, Stephan ^a   Salopek, Sanja ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; CREATININE; GELATIN; HETASTARCH; N ACETYL BETA GLUCOSAMINIDASE; PLASMA SUBSTITUTE; SODIUM;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT;

EID: 0032757988     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199911000-00009     Document Type: Article

References (28)

1. Davidson I. Fluid resuscitation of shock: current controversies. Crit Care Med 1989;7:1078-80.
2. Haljamäe H. Volume substitution in shock. Acta Anaesthesiol Scand 1993;37(Suppl 98):25-8.
3. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998;18:961-4.
4. Edwards JD. A new debate: colloid versus colloid? In: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Berlin: Springer, 1994:152-64.
5. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998;317:235-40.
6. Beards SC, Watt T, Edwards JD, et al. Comparison of the hemodynamic and oxygen transport response to modified fluid gelatin and hetastarch in critically ill patients: a prospective, randomized trial. Crit Care Med 1994;22:600-5.
7. Beyer R, Harmening U, Rittmeyer O, et al. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br J Anaesth 1997;78:44-50.
8. Lindeman RD. Changes in renal function with aging: implications for treatment. Drugs Aging 1992;2:423-31.
9. Ritschel WA. Gerontokinetics: the pharmacokinetics of drugs in the elderly patient. Caldwell, NJ: Telford Press, 1988:114-24.
10. Waldhausen P, Kiesewetter H, Leipnitz G, et al. Hydroxyethyl starch induced transient renal insufficiency in glomerular failure. Acta Med Austr 1991;18(Suppl 1):52-5.
11. Dehne MG, Mühling J, Sablotzki A, et al. Influence of hydroxethylstarch on renal function in intensive care patients. Anästhesiol Intensivmed Notfallmed Schmerzther 1997;32:348-54.
12. Legendre C, Thervet E, Page B, et al. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993;342:248-9.
13. Druml W, Pölzleitner D, Laggner AN, et al. Dextran-40, acute renal failure, and elevated plasma oncotic pressure. N Engl J Med 1988;318:252-3.
14. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996;348:1620-2.
15. Haskell PL, Tannenberg AM. Elevated urinary specific gravity in acute oligure renal failure due to hetastarch administration. N Y State J Med 1988;88:387-8.
16. Hussain SF, Drew PJT. Acute renal failure after infusion of gelatins. BMJ 1989;299:1137-8.
17. Dati F, Lammers M. Immunchemical methods for determination of urinary proteins (albumin and a1-microglobulin) in kidney disease. JIFCC 1989;1:68-77.
18. Dehne MG, Sablotzki, Mühling J, et al. Noninvasive diagnosis of acute renal failure in intensive care patients. Anaesthesist 1998; 47:193-201.
19. Schmid H, Guder WG. Distribution of diagnostically relevant enzymes along the nephron. In: Jung K, Mattenheimer H, Burchardt U, eds. Urinary enzymes in clinical and experimental medicine. Berlin: Springer, 1992:9-20.
20. Price RG. Measurement of N-acetyl-β-glucosaminidase and its isoenzymes in urine methods and clinical applications. Eur J Clin Chem Clin Biochem 1992;30:693-705.
21. Jung K, Schulze BD, Sydow K. Diagnostic significance of different urinary enzymes in patients suffering from chronic renal disease. Clin Chim Acta 1987;187:287-95.
22. Vogt NH, Bothner U, Lerch G, et al. Large dose administration of 6% hydroxyethyl starch 200/0.5 for total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 1996;83:262-8.
23. Köhler H, Zschiedrich H, Clasen R, et al. The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% Dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers. Anaesthesist 1982;31:61-7.
24. Griem W, Czok G, Lang K. Histologische und physiologische Untersuchungen an Ratten nach Verabreichung des Plasmaexpanders Gelifundol. Anaesthesist 1964;13:321-4.
25. Kief H, Engelhart K. Reabsorptive Vacuolisation der gewundenen Nierenhauptstücke (sog. osmotische Nephrose). Frank Zeitschr Pathol 1966;75:53-9.
26. Iana A, Schwartz D. Renal tubular cellular and molecular events in acute renal failure. Nephron 1994;68:413-8.
27. Chinitz JL, Kim KE, Onesti G, Swartz C. Pathophysiology and prevention of Dextran-40-induced anuria. J Lab Clin Med 1971; 77:76-87.
28. Rozich JD, Paul RV. Acute renal failure precipitated by elevated colloid osmotic pressure. Am J Med 1989;87:358-60.